FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119701105> ?p ?o ?g. }

• W2119701105 endingPage "e54163" @default.
• W2119701105 startingPage "e54163" @default.
• W2119701105 abstract "Background Mild traumatic brain injury (mTBI) secondary to blast exposure is the most common battlefield injury in Southwest Asia. There has been little prospective work in the combat setting to test the efficacy of new countermeasures. The goal of this study was to compare the efficacy of N-acetyl cysteine (NAC) versus placebo on the symptoms associated with blast exposure mTBI in a combat setting. Methods This study was a randomized double blind, placebo-controlled study that was conducted on active duty service members at a forward deployed field hospital in Iraq. All symptomatic U.S. service members who were exposed to significant ordnance blast and who met the criteria for mTBI were offered participation in the study and 81 individuals agreed to participate. Individuals underwent a baseline evaluation and then were randomly assigned to receive either N-acetyl cysteine (NAC) or placebo for seven days. Each subject was re-evaluated at 3 and 7 days. Outcome measures were the presence of the following sequelae of mTBI: dizziness, hearing loss, headache, memory loss, sleep disturbances, and neurocognitive dysfunction. The resolution of these symptoms seven days after the blast exposure was the main outcome measure in this study. Logistic regression on the outcome of ‘no day 7 symptoms’ indicated that NAC treatment was significantly better than placebo (OR = 3.6, p = 0.006). Secondary analysis revealed subjects receiving NAC within 24 hours of blast had an 86% chance of symptom resolution with no reported side effects versus 42% for those seen early who received placebo. Conclusion This study, conducted in an active theatre of war, demonstrates that NAC, a safe pharmaceutical countermeasure, has beneficial effects on the severity and resolution of sequelae of blast induced mTBI. This is the first demonstration of an effective short term countermeasure for mTBI. Further work on long term outcomes and the potential use of NAC in civilian mTBI is warranted. Trial Registration ClinicalTrials.gov NCT00822263" @default.
• W2119701105 created "2016-06-24" @default.
• W2119701105 creator A5009236903 @default.
• W2119701105 creator A5037155253 @default.
• W2119701105 creator A5064860257 @default.
• W2119701105 creator A5080849439 @default.
• W2119701105 creator A5086984046 @default.
• W2119701105 date "2013-01-23" @default.
• W2119701105 modified "2023-10-15" @default.
• W2119701105 title "Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study" @default.
• W2119701105 cites W1557930621 @default.
• W2119701105 cites W1894743091 @default.
• W2119701105 cites W1971377483 @default.
• W2119701105 cites W1983182638 @default.
• W2119701105 cites W1984170705 @default.
• W2119701105 cites W1984788006 @default.
• W2119701105 cites W1985387212 @default.
• W2119701105 cites W1997358531 @default.
• W2119701105 cites W2002492859 @default.
• W2119701105 cites W2005543346 @default.
• W2119701105 cites W2007437940 @default.
• W2119701105 cites W2028877394 @default.
• W2119701105 cites W2029893677 @default.
• W2119701105 cites W2035040528 @default.
• W2119701105 cites W204582743 @default.
• W2119701105 cites W2048212233 @default.
• W2119701105 cites W2058764818 @default.
• W2119701105 cites W2063753583 @default.
• W2119701105 cites W2065177605 @default.
• W2119701105 cites W2068710494 @default.
• W2119701105 cites W2070588749 @default.
• W2119701105 cites W2074086852 @default.
• W2119701105 cites W2084646646 @default.
• W2119701105 cites W2089053683 @default.
• W2119701105 cites W2090411921 @default.
• W2119701105 cites W2105388269 @default.
• W2119701105 cites W2106441030 @default.
• W2119701105 cites W2116039993 @default.
• W2119701105 cites W2125099055 @default.
• W2119701105 cites W2127091487 @default.
• W2119701105 cites W2136725788 @default.
• W2119701105 cites W2142089959 @default.
• W2119701105 cites W2144376710 @default.
• W2119701105 cites W2147886079 @default.
• W2119701105 cites W2150623659 @default.
• W2119701105 cites W2169828275 @default.
• W2119701105 cites W2246924591 @default.
• W2119701105 doi "https://doi.org/10.1371/journal.pone.0054163" @default.
• W2119701105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3553161" @default.
• W2119701105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23372680" @default.
• W2119701105 hasPublicationYear "2013" @default.
• W2119701105 type Work @default.
• W2119701105 sameAs 2119701105 @default.
• W2119701105 citedByCount "161" @default.
• W2119701105 countsByYear W21197011052013 @default.
• W2119701105 countsByYear W21197011052014 @default.
• W2119701105 countsByYear W21197011052015 @default.
• W2119701105 countsByYear W21197011052016 @default.
• W2119701105 countsByYear W21197011052017 @default.
• W2119701105 countsByYear W21197011052018 @default.
• W2119701105 countsByYear W21197011052019 @default.
• W2119701105 countsByYear W21197011052020 @default.
• W2119701105 countsByYear W21197011052021 @default.
• W2119701105 countsByYear W21197011052022 @default.
• W2119701105 countsByYear W21197011052023 @default.
• W2119701105 crossrefType "journal-article" @default.
• W2119701105 hasAuthorship W2119701105A5009236903 @default.
• W2119701105 hasAuthorship W2119701105A5037155253 @default.
• W2119701105 hasAuthorship W2119701105A5064860257 @default.
• W2119701105 hasAuthorship W2119701105A5080849439 @default.
• W2119701105 hasAuthorship W2119701105A5086984046 @default.
• W2119701105 hasBestOaLocation W21197011051 @default.
• W2119701105 hasConcept C118552586 @default.
• W2119701105 hasConcept C142724271 @default.
• W2119701105 hasConcept C169900460 @default.
• W2119701105 hasConcept C172467417 @default.
• W2119701105 hasConcept C1862650 @default.
• W2119701105 hasConcept C187212893 @default.
• W2119701105 hasConcept C204787440 @default.
• W2119701105 hasConcept C27081682 @default.
• W2119701105 hasConcept C2781017439 @default.
• W2119701105 hasConcept C71924100 @default.
• W2119701105 hasConceptScore W2119701105C118552586 @default.
• W2119701105 hasConceptScore W2119701105C142724271 @default.
• W2119701105 hasConceptScore W2119701105C169900460 @default.
• W2119701105 hasConceptScore W2119701105C172467417 @default.
• W2119701105 hasConceptScore W2119701105C1862650 @default.
• W2119701105 hasConceptScore W2119701105C187212893 @default.
• W2119701105 hasConceptScore W2119701105C204787440 @default.
• W2119701105 hasConceptScore W2119701105C27081682 @default.
• W2119701105 hasConceptScore W2119701105C2781017439 @default.
• W2119701105 hasConceptScore W2119701105C71924100 @default.
• W2119701105 hasIssue "1" @default.
• W2119701105 hasLocation W21197011051 @default.
• W2119701105 hasLocation W21197011052 @default.
• W2119701105 hasLocation W21197011053 @default.
• W2119701105 hasLocation W21197011054 @default.
• W2119701105 hasLocation W21197011055 @default.

• next